What's Going On With ALX Oncology Stock?
Portfolio Pulse from Henry Khederian
ALX Oncology Holdings Inc (NASDAQ:ALXO) announced the pricing of a public offering of approximately 7.37 million common stock shares at $6.38 per share and 1.25 million pre-funded warrants at $6.379 per warrant. The gross proceeds are expected to be around $55.0 million. The company plans to use the proceeds for clinical development and general corporate purposes.
October 05, 2023 | 2:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ALX Oncology's public offering could potentially increase the company's stock liquidity and provide funds for clinical development and corporate purposes.
The public offering will increase the number of shares available in the market, potentially increasing liquidity. The funds raised will be used for clinical development and corporate purposes, which could strengthen the company's position and potentially increase its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100